Maccarrone M et al. |
Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture. |
2001 |
J. Neurochem. |
pmid:11208922
|
Kagota S et al. |
2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. |
2001 |
Eur. J. Pharmacol. |
pmid:11275004
|
Bisogno T et al. |
The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. |
2001 |
Eur. J. Biochem. |
pmid:11277920
|
Wilson RI and Nicoll RA |
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. |
2001 |
Nature |
pmid:11279497
|
Di Marzo V et al. |
Leptin-regulated endocannabinoids are involved in maintaining food intake. |
2001 |
Nature |
pmid:11298451
|
Kobayashi Y et al. |
Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. |
2001 |
J. Biochem. |
pmid:11328586
|
Kozak KR et al. |
Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol. |
2001 |
J. Biol. Chem. |
pmid:11402053
|
Giuffrida A et al. |
Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11408519
|
Wang Y et al. |
Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. |
2001 |
Anal. Biochem. |
pmid:11412008
|
Suhara Y et al. |
Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2001 |
Bioorg. Med. Chem. Lett. |
pmid:11454463
|
Maccarrone M et al. |
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages. |
2001 |
J. Neurochem. |
pmid:11461969
|
Yamaguchi T et al. |
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice. |
2001 |
Brain Res. |
pmid:11478928
|
Di Marzo V et al. |
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. |
2001 |
Biochem. J. |
pmid:11485574
|
Stella N and Piomelli D |
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. |
2001 |
Eur. J. Pharmacol. |
pmid:11513837
|
Hansen HH et al. |
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. |
2001 |
J. Neurochem. |
pmid:11579150
|
Fowler CJ et al. |
Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. |
2001 |
Biochem. Pharmacol. |
pmid:11585048
|
Panikashvili D et al. |
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. |
2001 |
Nature |
pmid:11586361
|
Savinainen JR et al. |
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. |
2001 |
Br. J. Pharmacol. |
pmid:11588122
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|
Kurihara J et al. |
2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves. |
2001 |
Jpn. J. Pharmacol. |
pmid:11676206
|
van der Stelt M et al. |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
2001 |
J. Neurosci. |
pmid:11698588
|
Wagner JA et al. |
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. |
2001 |
J. Am. Coll. Cardiol. |
pmid:11738314
|
Al-Hayani A et al. |
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. |
2001 |
Neuropharmacology |
pmid:11747904
|
Darmani NA |
The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:11752094
|
Mechoulam R et al. |
Cannabinoids and brain injury: therapeutic implications. |
2002 |
Trends Mol Med |
pmid:11815270
|
Jordà MA et al. |
Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. |
2002 |
Blood |
pmid:11929767
|
Sugiura T and Waku K |
2-arachidonoylglycerol: an endogenous cannabinoid receptor agonist. |
2001 |
World Rev Nutr Diet |
pmid:11935957
|
Bisogno T et al. |
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. |
2002 |
Curr. Pharm. Des. |
pmid:11945157
|
Kozak KR et al. |
15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist. |
2002 |
J. Biol. Chem. |
pmid:11956198
|
Romero J et al. |
Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. |
2002 |
Brain Res. Mol. Brain Res. |
pmid:12008024
|
Vannacci A et al. |
Down-regulation by cannabinoids of the immunological activation of human basophils and guinea pig mast cells. |
2002 |
Inflamm. Res. |
pmid:12013387
|
Kreitzer AC and Regehr WG |
Retrograde signaling by endocannabinoids. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12049940
|
Nakane S et al. |
2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. |
2002 |
Arch. Biochem. Biophys. |
pmid:12051682
|
Sugiura T et al. |
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052034
|
Fowler CJ and Jacobsson SO |
Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052035
|
Högestätt ED and Zygmunt PM |
Cardiovascular pharmacology of anandamide. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052048
|
Kirkham TC et al. |
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. |
2002 |
Br. J. Pharmacol. |
pmid:12055133
|
Kojima S et al. |
Contractile response to a cannabimimetic eicosanoid, 2-arachidonoylglycerol, of longitudinal smooth muscle from the guinea-pig distal colon in vitro. |
2002 |
Eur. J. Pharmacol. |
pmid:12063081
|
Lichtman AH et al. |
Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12065702
|
Sugiura T and Waku K |
Cannabinoid receptors and their endogenous ligands. |
2002 |
J. Biochem. |
pmid:12097154
|
Dinh TP et al. |
Brain monoglyceride lipase participating in endocannabinoid inactivation. |
2002 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12136125
|
Matias I et al. |
Presence and regulation of the endocannabinoid system in human dendritic cells. |
2002 |
Eur. J. Biochem. |
pmid:12153574
|
van der Stelt M et al. |
Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. |
2002 |
J. Med. Chem. |
pmid:12166944
|
Gubellini P et al. |
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. |
2002 |
J. Neurosci. |
pmid:12177188
|
Kozak KR et al. |
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. |
2002 |
J. Biol. Chem. |
pmid:12244105
|
Rouzer CA et al. |
Chemical stability of 2-arachidonylglycerol under biological conditions. |
2002 |
Chem. Phys. Lipids |
pmid:12270674
|
Laine K et al. |
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. |
2002 |
Invest. Ophthalmol. Vis. Sci. |
pmid:12356827
|
González S et al. |
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. |
2002 |
Brain Res. |
pmid:12393235
|
Jordà MA et al. |
The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation. |
2003 |
Blood |
pmid:12406867
|
van der Stelt M et al. |
Acute neuronal injury, excitotoxicity, and the endocannabinoid system. |
2002 Oct-Dec |
Mol. Neurobiol. |
pmid:12428763
|